These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 11244304

  • 1. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Nephron; 2001 Feb; 87(2):111-7. PubMed ID: 11244304
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [Abstract] [Full Text] [Related]

  • 3. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Nephron; 1999 Jul; 82(1):32-8. PubMed ID: 10224482
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Nephron; 2000 Jun; 85(2):127-33. PubMed ID: 10867518
    [Abstract] [Full Text] [Related]

  • 5. Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Nephron; 1998 Jun; 78(4):403-9. PubMed ID: 9578066
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Am J Nephrol; 1999 Jun; 19(1):21-7. PubMed ID: 10085445
    [Abstract] [Full Text] [Related]

  • 7. Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome.
    Tomizawa S, Maruyama K, Nagasawa N, Suzuki S, Kuroume T.
    Nephron; 1985 Jun; 41(2):157-60. PubMed ID: 3876517
    [Abstract] [Full Text] [Related]

  • 8. Interleukin 10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis.
    Matsumoto K.
    Nephron; 1997 Jun; 75(2):154-9. PubMed ID: 9041534
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome.
    Maruyama K, Tomizawa S, Seki Y, Arai H, Kuroume T.
    Nephron; 1992 Jun; 62(1):27-30. PubMed ID: 1436287
    [Abstract] [Full Text] [Related]

  • 10. Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome.
    Heslan JM, Branellec AI, Pilatte Y, Lang P, Lagrue G.
    Clin Exp Immunol; 1991 Oct; 86(1):157-62. PubMed ID: 1914229
    [Abstract] [Full Text] [Related]

  • 11. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
    Kondo S, Yoshizawa N, Kusumi Y, Takeuchi A, Torikata C.
    Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FK 506 for vascular permeability factor production in minimal change nephrotic syndrome.
    Maruyama K, Tomizawa S, Seki Y, Arai H, Ogawa T, Kuroume T.
    Nephron; 1994 Nov; 66(4):486-7. PubMed ID: 7517020
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.